UBS Group’s Healthwell Acquisition Corp. I Class A Common Stock HWEL Stock Holding History
Bought
Maintained
Sold
Other funds holding HWEL
CCA
MF
AMH
RCM
PI
ACM
CF
AC
UBS Group's HWEL Position: Q1 2023 in Review
UBS Group sold out of Healthwell Acquisition Corp. I Class A Common Stock (HWEL) in Q1 2023, closing a stake of 1,464 shares — an estimated $14.5K sold.
UBS Group first reported a position in HWEL in Q4 2021 and held it in 5 quarters. The position peaked at $28K in Q4 2021. 45 funds tracked by Wall St. Rank hold HWEL as of Q1 2023.
- UBS Group reported no remaining Healthwell Acquisition Corp. I Class A Common Stock position as of Q1 2023 after selling out during the quarter.
- UBS Group sold 1,464 Healthwell Acquisition Corp. I Class A Common Stock shares in Q1 2023, an estimated $14.5K.
- UBS Group first reported a position in Healthwell Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 5 quarters.
- UBS Group's Healthwell Acquisition Corp. I Class A Common Stock position peaked at $28K in Q4 2021.
- 45 funds tracked by Wall St. Rank held Healthwell Acquisition Corp. I Class A Common Stock as of Q1 2023.
Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.